Journal Watch · Proceedings of the National Academy of Sciences (PNAS) · 2026

Mantis: A foundation model for mechanistic disease forecasting.

These capabilities illustrate that purely simulation-based foundation models such as Mantis can provide a practical foundation for disease forecasting: general-purpose, accurate, and deployable where traditional models struggle.

Dudley C, Magdaleno R, Harding C et al.Proceedings of the National Academy of Sciences (PNAS)3 min readPharma relevance 40/100

DOI: 10.1073/pnas.2602542123PMID: 42804637Study type: research study

TL;DR

These capabilities illustrate that purely simulation-based foundation models such as Mantis can provide a practical foundation for disease forecasting: general-purpose, accurate, and deployable where traditional models struggle.

Key findings

  • Across all other diseases tested, Mantis consistently ranked in the top two models across evaluation metrics.
  • Mantis further generalized to diseases with transmission mechanisms not represented in its training data, demonstrating that it can capture fundamental contagion dynamics rather than memorizing disease-specific patterns.
  • These capabilities illustrate that purely simulation-based foundation models such as Mantis can provide a practical foundation for disease forecasting: general-purpose, accurate, and deployable where traditional models struggle.

What they did

We evaluated Mantis against 78 forecasting models across 16 diseases with diverse transmission modes, assessing both point forecast accuracy [mean absolute error (MAE)] and probabilistic performance (weighted interval score and coverage). Despite using no real-world data during training, Mantis achieved lower MAE than all models in the CDC's COVID-19 Forecast Hub when backtested on early pandemic forecasts which it had not previously seen.

Full abstract (original)

Background: Infectious disease forecasting in novel outbreaks or low-resource settings is hampered by the need for large disease and covariate datasets, bespoke training, and expert tuning, all of which can hinder rapid generation of forecasts for new settings. To address these challenges, we developed Mantis, a foundation model trained entirely on mechanistic simulations, which enables out-of-the-box forecasting across diseases, regions, and outcomes, even in settings with limited historical data.

What they did: We evaluated Mantis against 78 forecasting models across 16 diseases with diverse transmission modes, assessing both point forecast accuracy [mean absolute error (MAE)] and probabilistic performance (weighted interval score and coverage). Despite using no real-world data during training, Mantis achieved lower MAE than all models in the CDC's COVID-19 Forecast Hub when backtested on early pandemic forecasts which it had not previously seen.

Results & conclusions: Across all other diseases tested, Mantis consistently ranked in the top two models across evaluation metrics. Mantis further generalized to diseases with transmission mechanisms not represented in its training data, demonstrating that it can capture fundamental contagion dynamics rather than memorizing disease-specific patterns. These capabilities illustrate that purely simulation-based foundation models such as Mantis can provide a practical foundation for disease forecasting: general-purpose, accurate, and deployable where traditional models struggle.

Abstract © the authors / Proceedings of the National Academy of Sciences (PNAS) (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1073/pnas.2602542123 · PubMed 42804637.

Why it matters for pharma & biotech

  • Relevant to General & Medicine teams tracking Proceedings of the National Academy of Sciences (PNAS) for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Proceedings of the National Academy of Sciences (PNAS) study find?

These capabilities illustrate that purely simulation-based foundation models such as Mantis can provide a practical foundation for disease forecasting: general-purpose, accurate, and deployable where traditional models struggle.

What type of study is this?

It is a research study, published in Proceedings of the National Academy of Sciences (PNAS) in 2026. We evaluated Mantis against 78 forecasting models across 16 diseases with diverse transmission modes, assessing both point forecast accuracy [mean absolute error (MAE)] and probabilistic performance (weighted interval score and coverage).

Where can I read the original paper?

The original is at the publisher via DOI 10.1073/pnas.2602542123. PubMed ID: 42804637. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Dudley C, Magdaleno R, Harding C et al.. Mantis: A foundation model for mechanistic disease forecasting.. Proceedings of the National Academy of Sciences (PNAS) (2026). DOI: 10.1073/pnas.2602542123.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/mantis-a-foundation-model-for-mechanistic-disease-forecasting-542123/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides